Literature DB >> 9196252

Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis.

R M Peek1, S F Moss, K T Tham, G I Pérez-Pérez, S Wang, G G Miller, J C Atherton, P R Holt, M J Blaser.   

Abstract

BACKGROUND: Infection with Helicobacter pylori induces chronic gastritis in virtually all infected persons, and such gastritis has been associated with an increased risk of developing gastric cancer. This risk is further enhanced with cagA+ (positive for cytotoxin-associated gene A) H. pylori strains and may be a consequence of induced gastric cell proliferation and/or alteration in apoptosis (programmed cell death) in the gastric epithelium.
PURPOSE: To determine whether the H. pylori cagA genotype and another virulence-related characteristic, the vacA (vacuolating cytotoxin A) s1a genotype, differentially affect epithelial cell proliferation, apoptosis, and the histologic parameters of inflammation and injury, we quantitated these characteristics in infected and uninfected persons.
METHODS: Fifty patients underwent upper gastrointestinal endoscopy, and biopsy specimens were taken. Apoptotic cells in the specimens were quantitated after terminal deoxynucleotidyl transferase labeling of DNA fragments with digoxigenin-deoxyuridine triphosphate; epithelial cell proliferation was scored by immunohistochemical analysis of the proliferation-associated antigen Ki-67. Antibodies directed against H. pylori and CagA protein were measured in the serum of patients by means of enzyme-linked immunosorbent assays. Analysis of H. pylori genomic DNA, by use of the polymerase chain reaction, was performed to determine the cagA and vacA genotypes. Acute and chronic inflammation, epithelial cell degeneration, mucin depletion, intestinal metaplasia, glandular atrophy, and vacuolation were each scored in a blinded manner. Reported P values are two-sided.
RESULTS: Persons harboring cagA+ strains (n = 20) had significantly higher gastric epithelial proliferation scores than persons infected with cagA-strains (n = 9) or uninfected persons (n = 21) (P = .025 and P<.001, respectively), but the difference in cell proliferation between the latter two groups was not statistically significant. The number of apoptotic cells per 100 epithelial cells (apoptotic index) in persons infected with cagA+ strains was lower than in persons infected with cagA-strains (P = .05). Apoptotic indices in the cagA+ group were similar to those in the uninfected group (P = .2). Epithelial cell proliferation was significantly correlated with acute gastric inflammation, but only in the cagA+ group (r = .44; P = .006). The cagA+ and vacA s1a genotypes were found to be concordant, confirming the close relationship between these virulence-related genotypes.
CONCLUSIONS: Gastric mucosal proliferation was significantly correlated with the severity of acute gastritis in persons infected with cagA+ vacA s1a strains of H. pylori. This increased proliferation was not accompanied by a parallel increase in apoptosis. IMPLICATIONS: Increased cell proliferation in the absence of a corresponding increase in apoptosis may explain the heightened risk for gastric carcinoma that is associated with infection by cagA+ vacA s1a strains of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196252     DOI: 10.1093/jnci/89.12.863

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  101 in total

1.  Effect of Helicobacter pylori infection on gastric epithelial cell proliferation.

Authors:  Hong Gao; Ji-Yao Wang; Xi-Zhong Shen; Jian-Jun Liu
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Molecular mechanisms of H. pylori associated gastric carcinogenesis.

Authors:  Zun-Wu Zhang; Michael JG Farthing
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

3.  Association between Helicobacter pylori and gastric cancer: current knowledge and future research.

Authors:  Harry Hua-Xiang Xia
Journal:  World J Gastroenterol       Date:  1998-04-15       Impact factor: 5.742

4.  Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA.

Authors:  Rupesh Chaturvedi; Mohammad Asim; Judith Romero-Gallo; Daniel P Barry; Svea Hoge; Thibaut de Sablet; Alberto G Delgado; Lydia E Wroblewski; M Blanca Piazuelo; Fang Yan; Dawn A Israel; Robert A Casero; Pelayo Correa; Alain P Gobert; D Brent Polk; Richard M Peek; Keith T Wilson
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

5.  Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.

Authors:  T I Kim; Y C Lee; K H Lee; J H Han; C Y Chon; Y M Moon; J K Kang; I S Park
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.

Authors:  D Kuck; B Kolmerer; C Iking-Konert; P H Krammer; W Stremmel; J Rudi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype.

Authors:  G Le'Negrate; V Ricci; V Hofman; B Mograbi; P Hofman; B Rossi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 8.  Stomach development, stem cells and disease.

Authors:  Tae-Hee Kim; Ramesh A Shivdasani
Journal:  Development       Date:  2016-02-15       Impact factor: 6.868

9.  Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions.

Authors:  J Yu; W K Leung; M Y Y Go; M C W Chan; K F To; E K W Ng; F K L Chan; T K W Ling; S C S Chung; J J Y Sung
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.